Case Name: GENZYME CORPORATION, Genzyme Surgical Products Corporation, Donald P. Elliott, Lynn Halseth, Nicholas F. D'antonio, and Nicholas J. D'Antonio, Plaintiffs-Appellants, v. ATRIUM MEDICAL CORPORATION, Defendants-Cross Appellants
Court: United States Court of Appeals for the Federal Circuit
Jurisdiction: United States
Decision Date: 2004-08-11
Citations: 108 F. App'x 619
Docket Number: No. 04-1409, 04-1430
Parties: GENZYME CORPORATION, Genzyme Surgical Products Corporation, Donald P. Elliott, Lynn Halseth, Nicholas F. D’antonio, and Nicholas J. D’Antonio, Plaintiffs-Appellants, v. ATRIUM MEDICAL CORPORATION, Defendants-Cross Appellants.
Judges: 
Reporter: West's Federal Appendix
Volume: 108
Pages: 619–619

Head Matter:
GENZYME CORPORATION, Genzyme Surgical Products Corporation, Donald P. Elliott, Lynn Halseth, Nicholas F. D’antonio, and Nicholas J. D’Antonio, Plaintiffs-Appellants, v. ATRIUM MEDICAL CORPORATION, Defendants-Cross Appellants.
No. 04-1409, 04-1430.
United States Court of Appeals, Federal Circuit.
Aug. 11, 2004.
Merriann M. Panarella, Principal Attorney, Wayne L. Stoner, Gregory P. Teran, William Lee, of Counsel, Wilmer Cutler, Boston, MA, for Defendant-Cross Appellant.
Donald R. Dunner, Principal Attorney, Finnegan, Henderson, Washington, DC, for Plaintiffs-Appellants.

Opinion:
ORDER
Atrium Medical Corporation moves to dismiss these appeals as premature. Atrium states that Genzyme Corporation et al. does not oppose.
Accordingly,
IT IS ORDERED THAT:
(1) The appeals are dismissed as premature.
(2) Each side shall bear its own costs.